Related Experiment Video
Updated: Sep 21, 2026
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Vitrectomy and subretinal injection of tissue plasminogen activator for large submacular hemorrhage secondary to AMD
Elad Moisseiev1, Tal Ben Ami, Adiel Barak
1Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv - Israel.
Purpose:
To evaluate the efficacy and safety of pars plana vitrectomy (PPV) with subretinal injection of tissue plasminogen activator (tPA) for the treatment of large submacular hemorrhage (SMH) secondary to age-related macular degeneration (AMD), and identify parameters correlated with the visual prognosis.
Methods:
Thirty-one eyes that underwent PPV with subretinal tPA injection for large SMH secondary to AMD were included in this retrospective study. Main outcome measure was improvement in at least one line in visual acuity (VA).
Results:
Improvement in VA was achieved in 14 (45.2%) patients. These patients had a significantly worse VA at presentation than patients who did not improve (p = 0.05). Central retinal thickness and earlier intervention were not correlated with the final visual prognosis. Postoperative complications included retinal detachment (19.3%), recurrent SMH (6.4%), and elevated intraocular pressure (6.4%).
Conclusions:
The VA at presentation is the most significant preoperative parameter associated with improvement in VA. A cutoff value of counting fingers VA is suggested, as patients with better VA at presentation did not benefit from surgery.
More Related Videos
11:03Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
Published on: January 22, 2018
11:20Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
